Alternate regimens for ovulation induction in polycystic ovarian disease.
The patient with PCOD remains a challenge to the reproductive endocrinologist. Although successful induction of ovulation can often be achieved using standard therapeutic regimens of CC or hMG, too often this group of anovulatory patients fails to respond as expected. Over the past 10 to 15 years, alternate approaches to ovulation induction have been investigated with encouraging results. Whereas no one method is productive in all patients, these varied regimens offer us a number of options in dealing with this difficult clinical problem.
Kelly
A C
AC
Department of Obstetrics and Gynecology, Columbia-Presbyterian Medical Center, New York, New York.
Jewelewicz
R
R
D002996:Clomiphene / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D005260:Female; D005640:Follicle Stimulating Hormone / Q000627:therapeutic use / Q000652:urine; D006801:Humans; D008596:Menotropins / Q000627:therapeutic use; D010062:Ovulation Induction / Q000379:methods*; D010906:Pituitary Hormone-Releasing Hormones / Q000627:therapeutic use; D011085:Polycystic Ovary Syndrome / Q000628:therapy* / Q000652:urine
D010906:Pituitary Hormone-Releasing Hormones; D002996:Clomiphene; D008596:Menotropins; D003907:Dexamethasone; D005640:Follicle Stimulating Hormone